Analysts’ Viewpoint on Polymerase Chain Reaction (PCR) Market Scenario
Manufacturers in the PCR market are increasing the production for nose swab PCR tests for accurate and reliable testing for the COVID-19 virus. However, it has been found that the accuracy of RT-PCR results rely heavily on sample collection timing, type, storage, handling, and processing. The tests diagnose active infection only and cannot detect whether an individual was infected previously. A false negative result is possible if the sample is not properly obtained or if an individual is tested too early after the exposure to the virus or too late in their infection. Nevertheless, companies in the market should boost output capacities for PCR tests due to the high prevalence of existing and potential infectious diseases.
The polymerase chain reaction (PCR) approach has been demonstrated to be effective in pharmaceutical and biotechnology research, as well as in microbiological quality control. Additionally, the approach is used in genetic engineering. Genetic engineering is one of the primary drivers for the expansion of the global polymerase chain reaction (PCR) market. PCR is being used to discover genes associated with specific phenotypes, such as genetic illnesses. The regular testing of raw materials and finished products for microbial contamination is a critical practice in pharmaceutical and biotechnology industries.
PCR is frequently used in critical processes for clinical laboratory research pertaining to various purposes, including biological research and criminal legal sciences. Polymerase chain reaction is a technique widely used to generate millions or billions of copies or duplicates or half-duplicates of a DNA, allowing researchers to take a small sample of DNA and intensify it (or a portion of it) to an enormous enough amount to concentrate exhaustively. Such findings are contributing toward growth of the PCR market.
The polymerase chain reaction test for COVID-19 is a molecular test that analyzes the upper respiratory specimen, looking for genetic material (ribonucleic acid or RNA) of SARS-CoV-2, the virus that causes COVID-19. Scientists are using the PCR technology to amplify small amounts of RNA from specimens into deoxyribonucleic acid (DNA), which is replicated until SARS-CoV-2 is detectable, if present. The PCR test has been emerging as the gold standard test for diagnosing COVID-19 since authorized for use in February 2020. Its accurate, convenient, and reliable outcome is being preferred by labs and research institutes.
Molecular diagnosis has transformed modern diagnostic science, and polymerase chain reaction has emerged as the method of choice for the early & reliable detection of diseases. The expansion of top manufacturers of PCR products in Asia Pacific through network strengthening and new product launches in developing countries are key factors expected to drive the polymerase chain reaction (PCR) market in the region during the forecast period.
Increase in incidence of cancer and infectious diseases has driven the demand for the use of polymerase chain reaction technique in clinical diagnosis of these diseases across Asia Pacific. The Korea Central Cancer Registry reported in 2016 that South Korea had 217,057 cancer cases in 2014. Such findings are fueling the growth of the Asia Pacific market.
Tuberculosis is one of the most widespread infectious illnesses, with a particularly high prevalence in developing nations. According to the World Health Organization (WHO), an estimated 10 million individuals were infected with tuberculosis globally in 2019. Thus, the PCR test has been recommended for quick detection of pulmonary tuberculosis, replacing the traditional sputum smear microscopy approach. China, India, and Indonesia were among the countries having a higher prevalence of the disease.
According to the World Health Organization (WHO), herpes simplex virus type 1 infects around 3.7 billion individuals worldwide. The rise in incidence of various infectious diseases is driving the demand for diagnostic products, which is expected to boost the growth of the PCR market.
The introduction of advanced reagents specific to the type of test is expected to propel the global demand for PCR reagents in the near future. PCR reagents include template DNA, PCR primers & probes, dNTPs, PCR buffers, enzymes, and master mixes. PCR consumables mostly include PCR tubes, plates, and other accessories required to conduct PCR reactions.
Manufacturers in the PCR market are increasing production for standard PCR systems, RT PCR systems, and digital PCR systems. The revenue share of digital PCR systems is expected to grow at a rapid pace during the forecast period. This is attributable to advantages of digital PCR systems such as precision, sensitivity, accuracy, reproducibility, direct quantification & multiplexing, and speed of analysis.
|
Attribute |
Detail |
|
Market Size Value in 2020 (Base Year) |
US$ 4.1 Bn |
|
Market Forecast Value in 2028 |
US$ 8.1 Bn |
|
Growth Rate (CAGR) |
6.4% |
|
Forecast Period |
2021–2028 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview. |
|
Format |
Electronic (PDF) |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Polymerase Chain Reaction Market – Segmentation
TMR’s study on the global polymerase chain reaction market includes information divided into four segments: product type, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global polymerase chain reaction market are discussed in detail.
| Product Type |
|
| End-user |
|
| Region |
|
PCR market is expected to cross the value of US$ 8.1 Bn by 2028
The market to expand at a CAGR of 6.4% from 2021 to 2028
The market is driven by rise in prevalence of tuberculosis and other infectious diseases
North America accounted for a major share of the global market
Key players in the global market include Bio-Rad Laboratories, Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc. Becton
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global PCR Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Trends
4.4. Global PCR Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Product Portfolio Analysis, by Key Players
5.2. Distributor Analysis, by Key Players
5.3. End-user Expectations from PCR Reagents & Instruments Manufacturers
5.4. Market Value Share Analysis (%): by PCR Technology
5.5. Clinical Diagnostic PCR Value Share (%) by Type of Diseases/Disorder
6. Global PCR Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2028
6.3.1. Instruments
6.3.1.1. Standard PCR Systems
6.3.1.2. RT PCR Systems
6.3.1.3. Digital PCR Systems
6.3.2. Reagents
6.3.3. Consumables
6.4. Market Attractiveness Analysis, by Product
7. Global PCR Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2028
7.3.1. Pharmaceutical & Biotechnology Industries
7.3.2. Clinical Diagnostics Labs & Hospitals
7.3.3. Academic & Research Organizations
7.3.4. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global PCR Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Rest of the World
8.3. Market Attractiveness Analysis, by Country/Region
9. North America PCR Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017–2028
9.2.1. Instruments
9.2.1.1. Standard PCR Systems
9.2.1.2. RT PCR Systems
9.2.1.3. Digital PCR Systems
9.2.2. Reagents
9.2.3. Consumables
9.3. Market Value Forecast, by End-user, 2017–2028
9.3.1. Pharmaceutical & Biotechnology Industries
9.3.2. Clinical Diagnostics Labs & Hospitals
9.3.3. Academic & Research Organizations
9.3.4. Others
9.4. Market Value Forecast, by Country, 2017–2028
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. by Product
9.5.2. by End-user
9.5.3. by Country
10. Europe PCR Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2028
10.2.1. Instruments
10.2.1.1. Standard PCR Systems
10.2.1.2. RT PCR Systems
10.2.1.3. Digital PCR Systems
10.2.2. Reagents
10.2.3. Consumables
10.3. Market Value Forecast, by End-user, 2017–2028
10.3.1. Pharmaceutical & Biotechnology Industries
10.3.2. Clinical Diagnostics Labs & Hospitals
10.3.3. Academic & Research Organizations
10.3.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2028
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. by Product
10.5.2. by End-user
10.5.3. by Country/Sub-region
11. Asia Pacific PCR Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2028
11.2.1. Instruments
11.2.1.1. Standard PCR Systems
11.2.1.2. RT PCR Systems
11.2.1.3. Digital PCR Systems
11.2.2. Reagents
11.2.3. Consumables
11.3. Market Value Forecast, by End-user, 2017–2028
11.3.1. Pharmaceutical & Biotechnology Industries
11.3.2. Clinical Diagnostics Labs & Hospitals
11.3.3. Academic & Research Organizations
11.3.4. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2028
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. by Product
11.5.2. by End-user
11.5.3. by Country/Sub-region
12. Rest of the World PCR Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2028
12.2.1. Instruments
12.2.1.1. Standard PCR Systems
12.2.1.2. RT PCR Systems
12.2.1.3. Digital PCR Systems
12.2.2. Reagents
12.2.3. Consumables
12.3. Market Value Forecast, by End-user, 2017–2028
12.3.1. Pharmaceutical & Biotechnology Industries
12.3.2. Clinical Diagnostics Labs & Hospitals
12.3.3. Academic & Research Organizations
12.3.4. Others
12.4. Market Attractiveness Analysis
12.4.1. by Product
12.4.2. by End-user
13. Competition Landscape
13.1. Market Player - Competition Matrix Competition Matrix (by tier and size of companies)
13.2. Market Share Analysis by Company (2020)
13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
13.3.1. Bio-Rad Laboratories, Inc.
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Product Portfolio
13.3.1.3. SWOT Analysis
13.3.1.4. Financial Overview
13.3.1.5. Strategic Overview
13.3.2. QIAGEN N.V.
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Product Portfolio
13.3.2.3. SWOT Analysis
13.3.2.4. Financial Overview
13.3.2.5. Strategic Overview
13.3.3. F. Hoffmann-La Roche AG
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Product Portfolio
13.3.3.3. SWOT Analysis
13.3.3.4. Financial Overview
13.3.3.5. Strategic Overview
13.3.4. Thermo Fisher Scientific, Inc.
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Product Portfolio
13.3.4.3. SWOT Analysis
13.3.4.4. Financial Overview
13.3.4.5. Strategic Overview
13.3.5. Becton, Dickinson and Company
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Product Portfolio
13.3.5.3. SWOT Analysis
13.3.5.4. Financial Overview
13.3.5.5. Strategic Overview
13.3.6. Abbott
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Product Portfolio
13.3.6.3. SWOT Analysis
13.3.6.4. Financial Overview
13.3.6.5. Strategic Overview
13.3.7. Siemens Healthcare GmbH (Siemens AG)
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Product Portfolio
13.3.7.3. SWOT Analysis
13.3.7.4. Financial Overview
13.3.7.5. Strategic Overview
13.3.8. BioMérieux SA
13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.8.2. Product Portfolio
13.3.8.3. SWOT Analysis
13.3.8.4. Financial Overview
13.3.8.5. Strategic Overview
13.3.9. Danaher Corporation
13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.9.2. Product Portfolio
13.3.9.3. SWOT Analysis
13.3.9.4. Financial Overview
13.3.9.5. Strategic Overview
13.3.10. Agilent Technologies
13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.10.2. Product Portfolio
13.3.10.3. SWOT Analysis
13.3.10.4. Financial Overview
13.3.10.5. Strategic Overview
List of Tables
Table 01: Global PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 02: Global PCR Market Size (US$ Mn) Forecast, by Instruments, 2017–2028
Table 03: Global PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 04: Global PCR Market Size (US$ Mn) Forecast, by Region, 2017–2028
Table 05: North America PCR Market Size (US$ Mn) Forecast, by Country, 2017–2028
Table 06: North America PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 07: North America PCR Market Size (US$ Mn) Forecast, by Instruments, 2017–2028
Table 08: North America PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 09: U.S. PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 10: U.S. PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 11: Canada PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 12: Canada PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 13: Europe PCR Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 14: Europe PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 15: Europe PCR Market Size (US$ Mn) Forecast, by Instruments, 2017–2028
Table 16: Europe PCR Market Size (US$ Mn) Forecast, by Industry, 2017–2028
Table 17: Germany PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 18: Germany PCR Market Size (US$ Mn) Forecast, of Industry, 2017–2028
Table 19: France PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 20: France PCR Market Size (US$ Mn) Forecast, Industry, 2017–2028
Table 21: Italy PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 22: Italy PCR Market Size (US$ Mn) Forecast, Industry, 2017–2028
Table 23: U.K. PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 24: U.K. PCR Market Size (US$ Mn) Forecast, Industry, 2017–2028
Table 25: Russia PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 26: Russia PCR Market Size (US$ Mn) Forecast, Industry, 2017–2028
Table 27: Spain PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 28: Spain PCR Market Size (US$ Mn) Forecast, Industry, 2017–2028
Table 29: Asia Pacific PCR Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
Table 30: Asia Pacific PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 31: Asia Pacific PCR Market Size (US$ Mn) Forecast, by Instruments, 2017–2028
Table 32: Asia Pacific PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 33: China PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 34: China PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 35: India PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 36: India PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 37: Japan PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 39: Japan PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 40: Australia & New Zealand PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 41: Australia & New Zealand PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028
Table 42: Rest of the World PCR Market Size (US$ Mn) Forecast, by Product, 2017–2028
Table 43: Rest of the World PCR Market Size (US$ Mn) Forecast, by Instruments, 2017–2028
Table 44: Rest of the World PCR Market Size (US$ Mn) Forecast, by End-user, 2017–2028
List of Figures
Figure 01: Global PCR Market Snapshot
Figure 02: Global PCR Market Size (US$ Mn) Forecast, 2017–2028
Figure 03: Market Value Share (%), by End-user (2017)
Figure 04: Market Value Share (%), by Region (2017)
Figure 05: Market Value Share (%), by Product (2017)
Figure 06: Global PCR Market Value Share (%), by Product, 2017 and 2028
Figure 07: Global PCR Market Attractiveness Analysis, by Product, 2021–2026
Figure 08: Global PCR Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Instruments Method, 2017–2028
Figure 09: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Reagents Method, 2017–2028
Figure 10: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Consumables Method, 2020–2028
Figure 11: Global PCR Market Value Share (%), by End-user, 2020 and 2028
Figure 12: Global PCR Market Value Share (%), by End-user, 2020 and 2028
Figure 13: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Pharmaceutical & Biotechnology Industries, 2020–2028
Figure 14: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinical Diagnostics Labs & Hospitals, 2020–2028
Figure 15: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Academic & Research Organizations, 2020–2028
Figure 16: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2020–2028
Figure 17: Global PCR Market Attractiveness Analysis, by Region, 2020–2028
Figure 18: Global PCR Market Value Share (%), by Region, 2017 and 2028
Figure 19: North America PCR Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028
Figure 20: North America PCR Market Value Share, by Country, 2020 and 2028
Figure 21: North America PCR Market Attractiveness Analysis, by Country, 2020–2028
Figure 22: North America PCR Market Value Share (%), by Product, 2020 and 2028
Figure 23: North America PCR Market Attractiveness Analysis, by Product, 2020–2028
Figure 24: North America PCR Market Value Share (%), by End-user, 2020 and 2028
Figure 25: North America PCR Market Attractiveness Analysis, by End-user, 2020–2028
Figure 26: Europe PCR Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2028
Figure 27: Europe PCR Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
Figure 28: Europe PCR Market Attractiveness Analysis, by Country/Sub-region, 2020–2028
Figure 29: Europe PCR Market Value Share (%), by Product, 2020 and 2028
Figure 30: Europe PCR Market Attractiveness Analysis, by Product, 2018 and 2026
Figure 31: Europe PCR Market Value Share (%), by Industry, 2020 and 2028
Figure 32: Europe PCR Market Attractiveness Analysis, by Industry, 2018-2026
Figure 33: Asia Pacific PCR Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028
Figure 34: Asia Pacific PCR Market Value Share, by Country/Sub-region, 2020 and 2028
Figure 35: Asia Pacific PCR Market Attractiveness Analysis, by Country/Sub-region, 2020–2028
Figure 36: Asia Pacific PCR Market Value Share (%), by Product, 2020 and 2028
Figure 37: Asia Pacific PCR Market Attractiveness Analysis, by Product, 2020–2028
Figure 38: Asia Pacific PCR Market Value Share (%), by End-user, 2020 and 2028
Figure 39: Asia Pacific PCR Market Attractiveness Analysis, by End-user, 2020–2028
Figure 40: Rest of the World PCR Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028
Figure 41: Rest of the World PCR Market Value Share (%), by Product, 2020 and 2028
Figure 42: Rest of the World PCR Market Attractiveness Analysis, by Product, 2020–2028
Figure 43: Rest of the World PCR Market Value Share (%), by End-user, 2020 and 2028
Figure 44: Rest of the World PCR Market Attractiveness Analysis, by End-user, 2020–2028
Figure 45: Company Share Analysis (%), 2017
Figure 46 Bio-Rad Laboratories, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2017–2020
Figure 47: Bio-Rad Laboratories, Inc. Breakdown of Net Sales, by Region, 2017
Figure 48: Bio-Rad Laboratories, Inc. Breakdown of Net Sales, by Business Segment, 2017
Figure 49: QIAGEN N.V. Breakdown of Net Sales, by Product Category, 2017
Figure 50: QIAGEN N.V. Revenue (US$ Mn) & Y-o-Y Growth (%), 2017–2020
Figure 51: QIAGEN N.V. Breakdown of Net Sales, by Region, 2017
Figure 52: F. Hoffmann-La Roche AG Revenue (US$ Bn) and Y-o-Y Growth (%), 2017–2020
Figure 53: F. Hoffmann-La Roche AG R&D Expenses, 2016–2017
Figure 54: F. Hoffmann-La Roche AG Breakdown of Net Sales, by Business Division, 2017
Figure 55: F. Hoffmann-La Roche AG Breakdown of Net Sales (Pharmaceutical Segment), by Region, 2017
Figure 56: Thermo Fisher Scientific, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2017–2020
Figure 57: Thermo Fisher Scientific, Inc. R&D Expenses, 2017–2020
Figure 58: Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Region, 2017
Figure 59: Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Business Segment, 2017
Figure 60: Becton, Dickinson and Company Revenue (US$ Bn) and Y-o-Y Growth (%), 2017–2020
Figure 61: Becton, Dickinson and Company R&D Intensity and Sales & Marketing Intensity – Company Level, (US$ Mn), 2016–2017
Figure 62: Becton, Dickinson and Company Breakdown of Net Sales, by Region, 2017
Figure 63: Becton, Dickinson and Company Breakdown of Net Sales, by Business Segment, 2017
Figure 64: Abbott Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2020
Figure 65: Abbott R&D Intensity and Sales & Marketing Intensity – Company Level, 2016–2017
Figure 66: Abbott Breakdown of Net Sales, by Segment, 2017
Figure 67: Abbott Breakdown of Net Sales (%), by Country, 2017
Figure 68: Siemens Healthcare GmbH Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 69: Siemens Healthcare GmbH Diagnostics Segment R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 70: Siemens Healthcare GmbH General and Administration Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 71: Siemens Healthcare GmbH Diagnostics Business Segment, Breakdown of Net Sales (%), by Region, 2017
Figure 72: Siemens Healthcare GmbH Diagnostics Business Segment, Breakdown of Net Sales (%), by Business Segment, 2017
Figure 73: bioMérieux SA Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2020
Figure 74: bioMérieux SA R & D Expenses (US$ Bn), 2017–2020
Figure 75: bioMérieux SA Breakdown of Net Sales, by Region, 2017
Figure 76: bioMérieux SA Breakdown of Net Sales, by Segment, 2017
Figure 77: Danaher Corporation Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2020
Figure 78: Danaher Corporation R & D Expenses
Figure 79: Danaher Corporation Breakdown of Net Sales, by Region, 2017
Figure 80: Danaher Corporation Breakdown of Net Sales, by Segment, 2017
Figure 81: Agilent Technologies Breakdown of Net Sales, by Segment, 2017
Figure 82: Agilent Technologies Breakdown of Net Sales, by Region, 2017
Figure 83: Agilent Technologies Revenue (US$ Mn) & Y-o-Y Growth (%), 2017–2020
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Polymerase Chain Reaction (PCR) Market
